"Dr. Neelapu showing spectacular data including in the CD19 CAR-exposed population: A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies #tandem23 https://t.co/0Eg1ehlEnD #TcellRx"

ADI-001 - Adicet Bio

Feb 15, 2023